Industry Focus

The Motley Fool's Kristine Harjes and Todd Campbell discuss what trial failure, commercial failure, and patent expiration at Celldex, MannKind, and PDL BioPharma, respectively, teaches investors about managing risk in the industry.

Extending a wave of industry consolidation, the No. 2 and 4 theater operators in the U.S. will combine to create the largest theater chain in the country. The combined entity will have over 8,000 screens and 600 locations in 45 states. And in other news, stellar revenue growth may soon be a source of nostalgia for Shake Shack investors.

Around the world, savers are grappling with negative interest rates. Here’s why negative interest rates are unlikely to hit American shores.

Years after the Great Financial Crisis, interest rates are heading even lower. From Japan to Germany, interest rates are so low that they’re negative -- that’s right, negative! Some investors are actually choosing to lose money by investing in government bonds.

But this week’s episode of Industry Focus: Financials has it all. Join us as The Motley Fool’s Gaby Lapera and Jordan Wathen discuss accounting ratios, negative interest rate policy, and why it’s so darn hard to make accurate predictions about the future.

Next week Fools will be on the ground in Austin for SXSW -- we run through three speakers we're excited to see and why.

We say goodbye to one of the nations pioneers and most controversial figures in America's shale revolution: Aubrey McClendon. Plus, a look at what Warren Buffet had to say about energy in his annual letter, ExxonMobil's big upcoming decisions, and we answer listener questions.